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Accessory proteins for heterotrimeric
G-proteins in the kidney
Frank Park*
Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis,
TN, USA
Heterotrimeric G-proteins play a fundamentally important role in regulating signal
transduction pathways in the kidney. Accessory proteins are being identified as direct
binding partners for heterotrimeric G-protein α or βγ subunits to promote more diverse
mechanisms by which G-protein signaling is controlled. In some instances, accessory
proteins can modulate the signaling magnitude, localization, and duration following
the activation of cell membrane-associated receptors. Alternatively, accessory proteins
complexed with their G-protein α or βγ subunits can promote non-canonical models of
signaling activity within the cell. In this review, we will highlight the expression profile,
localization and functional importance of these newly identified accessory proteins to
control the function of select G-protein subunits under normal and various disease
conditions observed in the kidney.
Keywords: G-proteins, accessory proteins, kidney, signal transduction, polycystic kidney disease, acute kidney
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Introduction
The kidney plays a fundamentally important role in controlling a wide array of physiological
processes, including fluid and electrolyte balance, hormone production, acid-base balance, and
blood pressure regulation (Alpern et al., 2013). Inmany of these biological functions, heterotrimeric
G-proteins play a crucial role through the stimulation of cell surface G-protein coupled receptors
(GPCRs) to activate diverse signaling networks depending upon their association with distinct
G-protein subunits (Wettschureck and Offermanns, 2005; Insel et al., 2007). To date, GPCRs
are a family of seven-transmembrane spanning integral membrane proteins with ∼800 different
members (Hollinger and Hepler, 2002), and are a common target for drug development. Canonical
signaling from GPCR activation was initially described as a ligand dependent mechanism that used
heterotrimeric G-proteins as an intermediary controller in the activation of intracellular signaling
cascades. In this mode of action, the GPCR functions as a guanine exchange factor (GEF) to
facilitate the replacement of GDP with GTP on the Gα subunit, and leads to a conformational
change in the heterotrimeric G-protein structure to promote effector system activation by Gα-GTP
and unbound Gβγ dimers. The intrinsic GTPase activity of the Gα subunit controls the rate by
which GTP is hydrolyzed to GDP resulting in re-association with Gβγ to inactivate heterotrimeric
G-protein function.
Over the past two decades, there is increasing evidence that the classic GPCR activation of
heterotrimeric G-proteins is more complex than original anticipated. The activation status of the
heterotrimeric G-protein can depend on a number of factors, including phosphorylation by kinases
(Tobin, 2008), adaptor proteins (Ritter and Hall, 2009; Magalhaes et al., 2012), and more recently,
the identification of accessory proteins that can selectively bind to individual G-protein subunits
Park Accessory proteins and the kidney
to regulate their activation status independent of GPCR input
(Hollinger and Hepler, 2002; Blumer et al., 2005, 2007). It
is becoming increasingly more evident that the complexity
of signaling output within the kidney is dependent upon the
repertoire of GPCR, G-protein subunits, and accessory proteins
located within an individual tissue and possibly each cell type.
The regulation by accessory proteins on heterotrimeric G-
proteins has shown little fanfare in the kidney. However, there
are an increasing number of studies that have demonstrated
the induction of previously unstudied accessory proteins in the
glomerulus, blood vessels or tubular epithelial cells leading to
an exaggerated response to a biological insult. In the following
sections of this review and summarized in Table 1, we will
categorize the accessory proteins in terms of its mode of action,
and where available, discuss their biological role in normal and
various disease states of the kidney, including cystic disease, acute
kidney injury, fibrosis, blood pressure regulation, and cancer.
Types of Accessory Proteins in the Normal
Kidney
In the normal kidney, there are an increasing number of
accessory proteins that have been detected using various
molecular techniques, but only a few have been described
to modulate some aspect of renal tubular function. Figure 1
illustrates the most common modes of action mediated by
accessory proteins to control the activation-inactivation cycle
of heterotrimeric G-proteins, and are defined in the following
categories: (1) GTPase-activating proteins (GAP); (2) guanine
exchange factors (GEF); (3) guanine dinucleotide dissociation
inhibitors (GDI); and (4) Gβγ-interacting proteins. Figure 2
provides a basic schematic of the protein domain structures for
the various accessory proteins.
GTPase-Activating Proteins (GAP)
Upon activation of Gα subunits following its binding with
GTP, Gα subunits have an intrinsic rate in which GTP can
be hydrolyzed back to GDP (Figure 1A). This leads to the re-
association with its native Gβγ partners, which inactivates the
G-protein signaling output back to control levels (Siderovski
and Willard, 2005). Accessory proteins known as GAPs can
short circuit the Gα-GTP activation state by accelerating GTP
catabolism (Siderovski and Willard, 2005).
G-protein Coupled Receptor Kinases (GRK)
This family of seven serine/threonine kinases has been well
established to play an integral role in the regulation of GPCR
activation (Kamal et al., 2012; Sato et al., 2015). Of the seven
GRKs, only five of the non-visual isoforms (GRK2-6) have been
identified to some degree in the mouse and human kidneys
(Gainetdinov et al., 2000; Felder et al., 2002). Each of the GRK
isoforms has a similar protein structure in which the N-terminus
contains a RGS homology domain that allows for the binding
with Gαq/11subunits, with a central core that possesses the kinase
activity domain. GRK2/3 is categorized as β-adrenergic kinases,
while GRK4-6 can be classified as the GRK4 group (Kamal et al.,
2012; Sato et al., 2015). GRK2/3 isoforms possess weak GAP
function to desensitize GPCR signaling by selective interaction
with Gαq/11subunits (Carman et al., 1999b); whereas GRK4 was
unable to bind to active Gαq or alter Gαq-dependent signaling
(Picascia et al., 2004). Another important domain in the C-
terminal region of GRK2/3 is the pleckstrin homology (PH)
region that can interact directly with Gβγ dimers. This dimeric
GRK2/3-Gβγ complex is capable of redistributing to the plasma
membrane (Daaka et al., 1997), and spatially orients GRK2/3 for
efficient phosphorylation of specific serine and threonine amino
acids in the active GPCR. This also enables β-arrestin to be
recruited, if needed, to the GPCR and act in concert with GRK2/3
to downregulate the GPCR and terminate G-protein signaling
(Kamal et al., 2012).
This type of desensitization phenomenon is observed in the
kidney on the dopamine type 1 receptor (D1R) by GRK2 during
states of oxidative stress (Banday and Lokhandwala, 2007).
Administration of lipoic acid, an antioxidant, could normalize
the GRK2 localization and restore the signaling function of the
D1R (Banday and Lokhandwala, 2007). Similar findings were
confirmed using other methods to control the oxidative stress
in the kidneys from hyperglycemic rat models (Trivedi and
Lokhandwala, 2005; Marwaha and Lokhandwala, 2006). Other
studies have identified GRK2 as a regulator of microtubule
assembly (Carman et al., 1999a) and cilia length (Kim et al.,
2010), which suggest that GRK may have broader functional
implications than the desensitization of GPCR activity.
Two other RGS proteins have shown expression in the kidney,
but their role to control renal function under normal conditions
needs further investigation:
RGS4
RGS4 functions as a GAP to promote deactivation of Gαq/11and
Gαi/o subunits in a cell-type dependent manner (Bansal et al.,
2007). In the mouse kidney, RGS4 was expressed predominantly
in the renal vasculature (Siedlecki et al., 2011; Pang et al., 2015).
RGS12
RGS12 is the largest RGS family member, which has
predominantly been studied for its extra-renal functions
in the bone system (Yang et al., 2013; Yuan et al., 2015).
Coincidentally, RGS12 was identified in a separate yeast screen
used to identify Activator of G-protein Signaling (AGS) proteins,
and was also named as AGS6 (Blumer et al., 2005, 2007). Recent
immunohistochemical analyses has shown that RGS12/AGS6
is robustly expressed in the endothelial cells of the renal
vasculature, and at a lesser intensity throughout the renal tubular
epithelia (Lenarczyk et al., 2015). Glomerular staining was
absent for RGS12/AGS6. Continued investigation into the role of
RGS12 is needed to determine its importance on renal function,
particularly with the availability of floxed RGS12 mice (Yang
et al., 2013; Yuan et al., 2015).
Guanine Exchange Factors (GEF)
Similar to the GEF function exhibited by GPCRs, some
intracellular accessory proteins can also bind inactive Gα
subunits to modulate the rate in which GDP can be swapped for a
molecule of GTP (Siderovski andWillard, 2005). These accessory
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TABLE 1 | Accessory proteins for heterotrimeric G-proteins in the kidney.
Functional
role
Accessory
protein
G-protein
subunit
Function References
I. NORMAL PHYSIOLOGY
Receptor
desensitization
GRK2/3 Gαq/11,Gβγ Promotes redistribution to plasma membrane to
inactivate GPCR signaling
Kamal et al., 2012; Sato et al., 2015
Cytoskeleton Tubulin Gαq, Gαi1, Gs Gα-GTP promotes microtubule Roychowdhury and Rasenick, 1994;
Yan et al., 1996; Roychowdhury
et al., 1999; Schappi et al., 2014
Gβγ Disassembly; Gβγ promotes microtubule
polymerization
Radixin Gα13-GTP Promotes conformational change to bind F-actin Vaiskunaite et al., 2000
Second
messenger
system
RGS2 Gαs,Gαq Partially inhibits water reabsorption by direct
interaction between RGS2 with Gαs and adenylyl
cyclase isoforms at the plasma membrane
Roy et al., 2003, 2006; Zuber et al.,
2007
Ion transporters AGS11/TFE3 Gα16 Regulates Npt2 expression Miyamoto and Itho, 2001
EBP50/NHERF1 Gαq Gαq inhibits PLC-β1 signaling by binding to the
same PDZ domains as PLC; dependency on
G-protein binding to alter sodium and phosphate
transport remains to be determined
Rochdi et al., 2002; Morales et al.,
2004
Glomerular
function
HSP90 Gα12, Gβγ Regulate GFR through NO-dependent mechanism;
role of G-proteins remains to be determined
Inanobe et al., 1994; Vaiskunaite
et al., 2001; Ramirez et al., 2008
II. PATHOPHYSIOLOGY/KIDNEY DISEASE
Cystic kidney
disease
RGS7 Gβ5 Interacts with C-terminal tail of PC-1; function
unknown
Kim et al., 1999
AGS3/GPSM1 Gαi/o Attenuates cystic disease progression; activates
heteromeric PC1/PC2 ion channel
Kwon et al., 2012; Nadella et al.,
2010
AGS5/LGN Gαi/o Loss of AGS5/LGN promotes abnormal cyst
formation in MDCK cells
Zheng et al., 2010; Xiao et al., 2012
AGS11/TFE3 Gα16 Associated with appearance of cysts in BHD;
mechanism not known
Luijten et al., 2013
HSP90 Gα12, Gβγ Accelerates cystic disease; role of G-proteins not
known
Seeger-Nukpezah et al., 2013
Acute kidney
injury
RGS4 Gαi Lack of RGS4 exacerbates the reduction in total
blood flow after IRI; RGS4 competes for activated
Gαq by ANGII to prevent secretion of RANTES
Siedlecki et al., 2011; Pang et al.,
2015
AGS1/Dexras1/RasD1 No known function Rusai et al., 2013; Zhang et al., 2013
AGS3/GPSM1 Gαi/o Promotes tubular epithelial cell repair following IRI Regner et al., 2011; Lenarczyk et al.,
2015
RACK1 Gβγ Induction of proximal tubular RACK1 expression
following IRI; functional role is not known
Padanilam and Hammerman, 1997
HSP90 Gα12 HSP90 induction in proximal tubules after IRI;
blockade of HSP90 activity reduces epithelial cells
damage after IRI, but due to compensatory
induction of other HSPs; over-expression of HSP90
restores coupling with eNOS after IRI to limit the
extent of epithelial cell damage after IRI; role of
G-protein interaction remains to be determined
Vaiskunaite et al., 2001
Glomerular
injury/disease
RGS2 Gαq RGS2 negatively regulates urotensin II-dependent
calcium increase and contraction
Adebiyi, 2014
GIV/Girdin Gαi/o Protects glomerulus from injury by activating
PI3K/Akt pathway
Wang et al., 2015
(Continued)
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TABLE 1 | Continued
Functional
role
Accessory
protein
G-protein
subunit
Function References
Rap1GAP Gαi/o Increased expression in podocytes from injury
glomeruli promoted cellular detachment by inhibition
activation of β1 integrin
Potla et al., 2014
Renal cancer AGS11/TFE3 Gα16 Associated with nuclear localization of hybrid
TFE3-fusion proteins in translocation renal cell
carcinoma
Meloni et al., 1993; Weterman et al.,
1996a,b, 2000, 2001; Kuiper et al.,
2003; Mathur and Samuels, 2007
Rap1GAP Gαi/o Loss of Rap1GAP promotes abnormal cell migration
and invasion
Kim et al., 2012
RGS5 Gαi/o Selectively expressed in the blood vessel in renal
cell carcinoma; may promote angiogenesis
Furuya et al., 2004
Fibrosis RGS2 Gαq Slows onset of renal fibrosis by blocking the AT1R
activated pro-fibrogenic and inflammatory systems
Jang et al., 2014
Vascular
hyperactivity
and
hypertension
RGS2 Gαq Loss of renal RGS2 produces mild hypertension Gurley et al., 2010
RACK1 Gβγ Hyperactive PLC/PKC increases vascular cell
proliferation in in hypertensive rats in vitro
Cheng et al., 2011
proteins can stabilize the active Gα-GTP complex to amplify the
G-protein signaling output (Figure 1B).
Activator of G-protein Signaling 1 (AGS1)
AGS1 was the first protein characterized from the AGS family,
and its sequence analysis was homologous to dexamethasone-
inducible Ras protein, DexRas1 (Cismowski et al., 1999). Studies
have determined that AGS1 acts as a GEF by selectively
potentiating the binding of GTP to Gαi subunit to promote
the activating signaling pathways (Cismowski et al., 1999, 2000,
2001; Tu and Wu, 1999). In the normal mouse and human
kidneys, AGS1 mRNA levels were detected at relatively low
levels (Kemppainen and Behrend, 1998; Tu and Wu, 1999;
Kemppainen et al., 2003), and AGS1 protein was exclusively
localized to the proximal tubules in the cortex and outer medulla
of the mouse kidneys (Lenarczyk et al., 2015).
Tubulin
Tubulin is ubiquitously expressed throughout the kidney, and
contributes to a number of biological functions associated with
the cytoskeleton, including the maintenance of normal cellular
morphology, cell migration, cell division, and intracellular
transport mechanisms (Schappi et al., 2014). Polymerization
of microtubules consists of a heterodimer of α- and β-tubulin
subunits that actively form upon binding to GTP. A number
of G-protein α subunits, namely αs, αi, and αq, can directly
interact with tubulin to control the dynamic stability of the
microtubules. In this scenario, tubulin exhibits a function similar
to a GEF, whereby GTP is bound by the β-subunit of tubulin
and transferred to Gα subunits to displace for the bound GDP
(Schappi et al., 2014). Upon the binding of either Gαs or Gαi1
to tubulin, the GTPase activity in tubulin is accelerated leading
to microtubule destabilization (Roychowdhury et al., 1999). The
intermediary role by which tubulin interacts with G-protein
subunits provides some insight as to the mechanism by which
GPCR activation transmits information from the external milieu
to the cytoskeleton.
Guanine Nucleotide Dissociation Inhibitors (GDI)
An evolutionarily conserved sequence known as the G-
protein regulatory (GPR) motif can bind selectively to inactive
Gαi/osubunits bound to GDP to exert diverse biological functions
within the cell (Siderovski and Willard, 2005) (Figure 1C).
Accessory proteins containing one or more of these GPR motifs
have been detected in the kidney, and function by maintaining
the Gαi subunit in the inactive GDP-bound state to prevent
the re-association with its native Gβγ partner. The functional
roles of GDI can be quite diverse by controlling mitotic
spindle orientation, asymmetric cell division, protein trafficking,
autophagic processes, and even regulate ligand-dependent GPCR
signaling at the cell membrane (Blumer and Lanier, 2014). All of
these functions associated with the GDI have not been identified
in the kidney, and the accessory proteins with one or more GPR
motifs and expressed in the kidney are listed below:
Activator of G-protein Signaling 3 (AGS3)
Activator of G-protein Signaling 3 (AGS3) is the third protein
identified from yeast screen attempting to identify receptor-
independent regulators of G-protein subunit activity (Cismowski
et al., 1999, 2001), and is also known as G-protein Signaling
Modulator 1 (GPSM1). AGS3/GPSM1 is an evolutionarily
conserved protein found in fruit flies to humans, and is a
tripartite protein in which there are seven tetratricopeptide
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FIGURE 1 | Schematic illustrating the four types of regulation
exhibited by accessory proteins on heterotrimeric G-protein
subunits. The four main types of regulation mediated by accessory proteins
are: (1) GTPase-activating proteins; (2) Guanine exchange factors;
(3) Guanine nucleotide dissociation inhibitors; and (4) Gβγ-interacting proteins.
(Continued)
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FIGURE 1 | Continued
Ligand activation promotes a conformational change in the heterotrimeric
G-protein associated with the GPCR, which facilitates the switch from
GDP to GTP-bound Gα subunits. Subsequently, this leads to the activation
of downstream effector systems by Gα-GTP and unbound Gβγ. The Gα
subunit has intrinsic GTPase activity to inactivate the signaling output and
ultimately, reassociate with its native Gβγ partner. Alternatively, an
accessory protein (Acc) functioning as a GAP can interact with Gα-GTP to
accelerate the deactivation of the signaling pathway (A). Other accessory
proteins can bind to the inactive form of Gα-GDP to either facilitate the
activity of Gα by increasing the switch from GDP-to-GTP bound Gα
subunits (known as GEFs; B) or bind one or more Gαi/o-GDP subunits to
activate other non-canonical signaling pathways (known as GDI; C). The
last major type of regulation by accessory proteins is a direct interaction
with Gβγ in the presence or absence of the associated Gα subunit (D). As
an example, an accessory protein (Acc), such as GRK2/3, can bind with
Gβγ to distribute the complex to the plasma membrane and phosphorylate
an active GPCR to downregulate its activity, or the physical interaction with
Gβγ could disrupt the activated Gβγ-dependent signaling by the unbound
dimer. It remains unclear whether accessory proteins complexed with Gβγ
promote their own unique signal processing. GPCR, G-protein coupled
receptor; αβγ, heterotrimeric G-protein α, β, and γ subunits; GDP, guanine
dinucleotide phosphate; GTP, guanine trinucleotide phosphate; Acc,
accessory protein.
repeats at the N-terminus followed by a short linker region
connecting four GPR motifs at the C-terminus (Blumer et al.,
2002). The expression of AGS3 in the normal rodent kidney
is predominantly localized to the collecting ducts in the renal
cortex and outer medulla (Nadella et al., 2010; Regner et al., 2011;
Kwon et al., 2012; Lenarczyk et al., 2015). Functionally, Gpsm1-
deficient mice are able to survive post-natal birth without any
adverse histological observations in the kidney (Regner et al.,
2011; Kwon et al., 2012). In vitro studies using proximal tubule
and collecting duct epithelial cells demonstrated reduced cell
numbers following genetic knockdown of endogenous AGS3
expression, which suggested that AGS3 may play a basal role in
controlling renal tubular epithelial cell viability (Nadella et al.,
2010; Regner et al., 2011). Further studies are needed to confirm
the role of AGS3 in the normal kidney.
AGS5
AGS5 is a homolog of AGS3, and is also known by other aliases,
including G-protein Signaling Modulator 2 (GPSM2) or more
commonly as Leu-Gly-Asn rich protein (LGN). AGS5 has a
similar protein structure to AGS3, which includes eight TPR in
the N-terminus and four GPR motifs in the C-terminus (Blumer
et al., 2002). Unlike AGS3, AGS5 is expressed ubiquitously
throughout the mammalian organs, including a high abundance
in the kidney (Blumer et al., 2002; Nadella et al., 2010; Regner
et al., 2011). AGS5 has been localized to the distal portion of
the nephron, specifically the thick ascending limbs of Henle
and the collecting ducts (Lenarczyk et al., 2015). Functionally,
AGS5/LGN is involved in the establishment of mitotic spindle
orientation along the polarity axis of the cell (Blumer et al., 2006).
The role of this phenomenon or other functions in the kidney
using AGS5/LGN-deficient mice, which are post-natally viable
(Konno et al., 2008), remains to be determined.
Rap1 GTPase-Activating Protein (Rap1GAP)
Rap G-proteins are a distinct subfamily of the Ras family of
small molecular weight GTPases (Spilker and Kreutz, 2010;
Gloerich and Bos, 2011), which can act as a GDI by virtue of
the presence of a GPR motif at the N-terminus. A previous
study by demonstrated that Rap1GAP could selectively bind to
GDP-bound Gαi subunits (Natochin et al., 2001), which was
subsequently shown to alter the localization of Rap protein
to the cell surface or target for proteosomal degradation
(Gloerich and Bos, 2011). Under normal homeostasis, the
expression pattern of Rap1GAP in the kidney is minimal
(Rubinfeld et al., 1991), and so its biological role remains largely
undefined.
Gβγ-interacting Proteins
There are an increasing number of proteins that can interact
directly with free Gβγ dimers or complexed as the αβγ
heterotrimers to control G-protein signaling (Figure 1D). It
is well established that unbound Gβγ can promote G-protein
dependent signaling, but the effect of an interaction by accessory
proteins with Gβγ on the magnitude, localization and duration
of the signaling output needs further investigation.
G-protein Coupled Receptor Kinases (GRK)
As discussed earlier, GRK2/3 interacts with the Gβγ subunits
with the C-terminal PH domains, which is unique to the GRK2/3
isoforms and not found in the other five GRKs. The newly
formed GRK2/3-Gβγ complex will translocate to the plasma
membrane for subsequent phosphorylation of the GPCR, which
will promote internalization of the GPCR into the cell through
an endocytic pathway and trafficked to lysosomes for recycling of
the components (Daaka et al., 1997).
Receptor for Activated Protein Kinase C 1 (RACK1)
RACK1 was initially cloned from a rat brain cDNA library
(Ron et al., 1994), and exhibits diverse cellular functions,
including activation by direct binding to the SH2 domain (Chang
et al., 1998), and binding to free Gβγ subunits (Chen et al.,
2004a,b). This type of protein-protein interaction by RACK1
has been shown to promote translocation of RACK1 to the
membrane and partially inhibit Gβ1γ1-, but not Gα-dependent
signaling in cells (Chen et al., 2004a,b). Under normal kidney
homeostasis, RACK1 expression was minimal (Padanilam and
Hammerman, 1997). However, in isolated pooled pre-glomerular
vascular smooth muscle cell lysates, a high abundance of RACK1
protein was detected using Western blot analysis (Cheng et al.,
2011). Genetic knockdown of endogenous RACK1 levels in both
vascular smooth muscle and glomerular mesangial cells were
observed to have a negative impact on cell number due to
a decrease in the level of intracellular calcium (Cheng et al.,
2011). The physiological effect of RACK1 in the renal tubules
and vasculature in the normal kidney in vivo remains to be
determined.
Tubulin
In some instances, tubulin has been shown to bind
selectively with Gβγ dimers to promote the assembly of
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FIGURE 2 | Protein domain structure in accessory proteins. Each of
the accessory proteins described in this review are drawn with their
respective domains using the wild-type protein sizes obtained from a
consensus human sequence. The protein structures are categorized by their
putative biological roles in regulating G-protein function as shown in
Figure 1: (A) GAP; (B) GEF; (C) GDI; and (D) Gβγ interaction. G-protein
subunits have been determined to interact within the RGS box, Gβ, GPR,
PH, or WD domains. In some accessory proteins listed in (E) “Alternate
mode of action,” the radixin protein has been identified to bind in the
N-terminal part of the protein and EBP50 interacts with Gαq in the PDZ
domains. The binding sites for HSP90 and AGS11 have yet to be
determined. RGS, Regulator of G-protein Signaling box; RBD, Ras binding
domain; TPR, tetratricopeptide repeat; GPR, G-protein regulatory motif; WD,
WD40 repeat; PDZ, PSD-95/Drosophila disk large/ZO-1 domains; PH,
pleckstrin homology domain; hATPase, human ATPase; ERM,
ezrin-radixin-moesin binding domain; HLH, helix-loop-helix.
microtubules (Roychowdhury and Rasenick, 1994), but
may be isoform-specific (Yan et al., 1996). The site of
interaction between Gβγ subunits with tubulin remains to be
determined.
Alternate Mechanisms of Action by Accessory
Protein-G Protein Interaction
Upon binding with specific subunits of the heterotrimeric G-
protein, the mode of action by which some accessory proteins
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alter G-protein function have either not been determined, or
act in a distinct mechanism outside of the four categories
listed earlier. In some cases, accessory proteins may undergo a
conformational change to act as a central scaffold to organize
signaling protein complexes, or mediate changes in organelle
localization within the cell to regulate its function.
Regulator of G-protein Signaling 2 (RGS2)
Regulator of G-protein Signaling 2 (RGS2) has been shown
to control the rate in which water is reabsorbed in mice
after dehydration (Zuber et al., 2007), i.e., Rgs2−/− mice
following dehydration reabsorbed more water during the initial
rehydration period compared to the wild-type mice (Zuber
et al., 2007). Consistent with its functional role in water
reabsorption, RGS2 was localized to nephron segments that
were vasopressin V2 receptor-positive and also essential for
generating the urine concentrating mechanism, which included
the thick ascending limbs of Henle, distal convoluted tubules,
and the entire length of the collecting duct (Zuber et al.,
2007; Adebiyi, 2014). Glomerular and renal vascular cells were
also observed to express RGS2, but minimal expression was
detected in the proximal convoluted tubules, or the thin limbs
of Henle. Coincidentally, RGS2 expression could be induced
following stimulation with arginine vasopressin (AVP) in both
isolated thick ascending limbs and cortical collecting ducts
(CCD) (Zuber et al., 2007). Moreover, accumulation of cAMP
in CCD following AVP stimulation was significantly higher in
the absence of RGS2 expression. Although RGS2 was initially
identified to selectively bind Gαq, the mechanism by which RGS2
regulates cAMP production appeared to be dependent upon
direct interaction with either or both Gαs and adenylyl cyclase
isoforms (Roy et al., 2003, 2006). Instead of RGS2 functioning
as a GAP on Gαs activity, RGS2-Gαs complexes promoted
a redistribution of RGS2 to the plasma membrane from the
nucleus. This enabled RGS2-Gαs to negatively impact cAMP
production by direct interaction with adenylyl cyclases (Roy et al.,
2006, 2003). These studies provide some evidence that water
reabsorption can be modulated by RGS2 in a mechanism that
does not appear to involve the canonical GAP activity on Gα
subunits.
Transcription Factor E3 (TFE3)
Transcription factor TFE3 is a member of the microphthalmia
(MiT) family of basic helix-loop-helix-leucine zipper
transcription factors (Argani and Ladanyi, 2005), and was
recently identified as an AGS protein (AGS11) by virtue of
its strong interaction with Gα16 and to a lesser extent, Gαs
subunits (Sato et al., 2011). A previous study demonstrated
that renal tubular phosphate reabsorption may be regulated by
TFE3 (Miyamoto and Itho, 2001). In mice fed a low phosphate
diet, NPT2 expression was elevated. Truncated forms of TFE3
induced NPT2 expression by directly binding to phosphate
response elements (PRE) using nuclear extracts isolated from
mouse proximal tubular cells. Further studies are needed
to confirm whether the mode of action by TFE3/AGS11
is through the altered nuclear translocation of G-protein
subunits in the kidney, but there is a previous study using
cardiomyocytes that an AGS11-Gα16 complex preferred nuclear
localization and was an essential step in the enhancement
of cardiomyocyte transcriptional activation (Sato et al.,
2011).
Radixin
Radixin is amember of the ezrin-radixin-moesin (ERM) family of
actin-binding proteins, which can function as a scaffold protein
between filamentous actin (F-actin) and membrane associated
proteins to regulate signal transduction pathways for fluid and
electrolyte balance and cytoskeletal remodeling. Radixin localizes
to the renal corpuscles and the brush border of the proximal
tubules (Ingraffea et al., 2002). Raxidin interacts selectively with
the active form of Gα13-GTP complexes, but not Gα12, and
promotes radixin to undergo a conformational change that
unmasks a high affinity binding site for F-actin at the C-terminus
(Vaiskunaite et al., 2000). Functionally, the specific role for
radixin-Gα13 has not been thoroughly investigated in the kidney,
and genetic removal of radixin in mice produces viable offspring
that exhibit relatively normal renal phenotype (Morales et al.,
2004). Considering that other members of the ERM family,
particularly ezrin, have high homology (∼75%) to the human
form of radixin, additional genetic knockouts of the ERM family
may be warranted to fully expose the biological role of radixin in
the kidney.
EBP50 (Ezrin-radixin-moesin-binding
Phosphoprotein 50)
Another scaffold protein associated with the ERM family is
EBP50, which was initially identified as a protein that can
bind to the N-terminal domain of ezrin or moesin (Reczek
et al., 1997). EBP50 is the human homolog of the rabbit Na+–
H+ exchanger regulatory factor 1 (NHERF1). In the kidney,
the distribution of mRNA expression for EBP50/NHERF1 was
localized to the glomerulus, proximal tubules, thick ascending
limbs of Henle and CCD by qualitative RT-PCR, but not the
thin descending limbs of Henle or the medullary collecting
ducts (Weinman et al., 1995). Immunohistochemistry using a
specific antibody toNHERF1 demonstrated exclusive localization
to the apical membrane in the proximal tubules (Miyazaki
et al., 2005). EBP50/NHERF1 can bind to a multitude of
proteins due to the presence of two interspaced PDZ domains
in the central compartment of the protein. The GTP-bound
form of Gαq was demonstrated to interact with both PDZ
domains in EBP50/NHERF1 (Rochdi et al., 2002), and interferes
with downstream activation of phospholipase C-β1 (PLC-
β1). Studies in EBP50 knockout mice demonstrated that the
absence of EBP50 resulted in a marked reduction in the
localization of ERM proteins to their typical site at the
brush border membrane in proximal tubules (Morales et al.,
2004), but whether abnormalities in G-protein signaling is
associated with this defect in compartmentalization is not well
established.
Heat Shock Protein 90 (HSP90)
Heat shock protein 90 (HSP90) is a molecular chaperone
protein that can interact with a large host of substrate proteins
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known as “clients.” Of the various heterotrimeric G-protein
subunits, Gα12, but not Gα13 subunits (Vaiskunaite et al.,
2001), as well as Gβγ (Inanobe et al., 1994) have been shown
to selectively bind with HSP90. To date, the precise site of
interaction with the G-protein subunits with HSP90 remains to
be determined. In the normal kidney, HSP90 is expressed at a
low level (Barrera-Chimal et al., 2014; Smithline et al., 2014),
and can be detected in the distal tubule and collecting duct
epithelial cells (Satoh et al., 1994), which are common sites of
Gα12 subunit localization (Zheng et al., 2003; Boucher et al.,
2012). Under normal conditions, HSP90 acts as a surveillance
system to ensure proper conformational protein production and
function, and its expression is induced during cellular stress
(Burrows et al., 2004; Whitesell and Lin, 2012). The role of
HSP90 in the kidney under basal conditions is not well defined,
but there is evidence that blockade of HSP90 function could
reduce glomerular filtration rate (GFR) through a nitric oxide-
dependent mechanism (Ramirez et al., 2008).
Accessory Proteins in Kidney Injury and
Disease
Cystic Kidney Disease
Cystic kidney disease is believed to be associated with a wide
range of genetic and environmental factors (Bisceglia et al., 2006),
and the most common form in humans is known as autosomal
dominant polycystic kidney disease (ADPKD). In ADPKD, a
mutant form of polycystin-1 (PC-1) protein is produced leading
to aberrant signaling pathways and phenotypic changes within
the renal tubular epithelial cell. These changes lead to the
transformation of the normal tubular epithelial cell to exhibit a
cystic phenotype resulting in the formation of numerous fluid-
filled sacs within the kidney.
PC-1 is an atypical G-protein coupled receptor (GPCR) due
to its 11 transmembrane-spanning regions. The C-terminal tail
of PC-1 is highly conserved across species, and contains a
20 amino acid G-protein activation domain that interacts and
increases the GTPase activity of various isotypes of G-protein
α subunits, including Gα12/13(Parnell et al., 1998, 2002; Yu
et al., 2011), Gαi1−3(Parnell et al., 1998, 2002) and Gαq (Parnell
et al., 1998). The effector systems activated by the Gα-PC-1
complex include c-Jun N-terminal kinase (JNK) and the AP-
1 transcription factor (Parnell et al., 2002) through Gα12 (Yu
et al., 2010, 2011), and Gαi interaction promotes increased pool
of Gβγ dimers leading to heteromeric polycystin-1/polycystin-
2 channel and G-protein inward rectifying K+ (GIRK) activity
(Delmas et al., 2002). Binding of G-protein subunits can be
antagonized by polycystin-2 (PC-2), which is known to interact
with the C-terminal end of PC-1, and control G-protein signaling
output (Delmas et al., 2002). This provides the opportunity for
other proteins in close proximity to the C-terminal tail of PC-
1 to control G-protein subunit binding and modulate G-protein
dependent signal transduction activity.
Regulator of G-protein Signaling 7 (RGS7)
RGS7, a rapidly degraded protein, was found to interact with the
C-terminal tail of PC-1 to redistribute to the plasma membrane
and prolong its stability (Kim et al., 1999). RGS7 belongs
to a subfamily of RGS proteins, which can selectively bind
to Gαo and Gαq subunits to accelerate the intrinsic GTPase-
activating function to catalyze the degradation of GTP to GDP
(Hollinger and Hepler, 2002). Subsequently, it was determined
that RGS7 contains a G-protein gamma-like (GGL) domain that
can selectively interact with the β5-subunit (Snow et al., 1998).
Unlike the G-protein α subunits, RGS7 was believed to interact
at the coiled coil domain (L4215-R4249) in PC-1 similar to
the site that binds to PC-2. It is not known whether RGS7 or
other accessory proteins would compete with PC-2 to control the
activity of the PC-2 ion channel. QTL analysis in the BPK mouse
model of ARPKD suggested that the region in Chr 1 containing
the RGS7 locus was considered to be a genetic modifier of
cystic disease (Guay-Woodford et al., 2000). However, there have
not been subsequent genetic studies to confirm their functional
relevance to regulate cystic disease progression. Moreover, the
sites of RGS7 localization in the kidney remains to be fully
determined, particularly its presence in cystic epithelial cells.
Activators of G-protein Signaling (AGS)
Subsequently, accessory proteins in the Activators of G-protein
Signaling (AGS) family have been identified to control the
transformation of renal tubular epithelial cells toward a cystic
phenotype in animal models. AGS proteins are another large
family of receptor-independent G-protein subunit regulators and
exhibit distinct mechanisms of action by binding directly to Gα
or Gβγ subunits (Blumer et al., 2005, 2007). There is histological
evidence that several of the AGS proteins, including AGS3, AGS5,
and AGS11, express in renal cystic tubular epithelial cells (Chen
et al., 2008; Nadella et al., 2010; Kwon et al., 2012; Lenarczyk et al.,
2015). No expression of AGS1 and AGS6 was detected in renal
cystic epithelial cells (Lenarczyk et al., 2015).
Activator of G-protein Signaling 3 (AGS3)
Activator of G-protein Signaling 3 (AGS3) [or G-protein
Signaling Modulator 1 (GPSM1)] mRNA and protein expression
was aberrantly high in cystic collecting duct epithelial cells from
multiple orthologous and non-orthologous rodent models of
autosomal recessive (ARPKD) and ADPKD (Nadella et al., 2010;
Kwon et al., 2012; Lenarczyk et al., 2015). Functional loss of
full-length AGS3/GPSM1 protein expression in the Pkd1V/V
mouse, a model of ADPKD, demonstrated an acceleration of
cystic disease progression in the kidneys (Kwon et al., 2012).
The signaling pathways affected by alterations in AGS3/GPSM1
protein expression have not been fully described in the context
of cystic epithelial cells, but there is compelling evidence in other
cell lines that AGS3/GPSM1 functions as a guanine dinucleotide
dissociation inhibitor (GDI) due to the presence of four GPR
motifs (Cismowski et al., 1999; Takesono et al., 1999). The GPR
motifs interact directly with one or more Gαi/o subunits bound
to GDP (12–14), which prevents the re-association with Gβγ
subunits and prolong Gβγ-dependent signaling as one mode of
action (Nadella et al., 2010; Regner et al., 2011; Kwon et al., 2012).
Consistent with this mechanism of action, over-expression of
AGS3/GPSM1 in the absence of a Gβγ scavenger was observed
to facilitate an increase of heteromeric PC-1/PC-2 ion channel
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activity (Kwon et al., 2012). Alternatively, there is recent evidence
that AGS3/GPSM1 interfaces with activated insulin growth factor
1 receptor (IGF-1R) at the cell membrane to control Gβγ-
dependent resorption of the cilia (Yeh et al., 2013). Further
studies are needed to fully understand the implications of the
AGS3-Gβγ signaling in the control of PC-1/PC-2 ion channel
function and cilia dynamics in renal tubular epithelial cells.
Activator of G-protein Signaling 5 (AGS5)
Similar to AGS3/GPSM1, AGS5 also known more commonly as
LGN, was detected in the distal tubular epithelial cells in ADPKD
kidneys (Lenarczyk et al., 2015). Unlike AGS3/GPSM1, however,
the protein levels of AGS5/LGN were not markedly changed
during the progression of cystic disease (Nadella et al., 2010).
An in vitro study using MDCK epithelial cells demonstrated
abnormal formation of cysts (Zheng et al., 2010; Xiao et al., 2012),
but the role for AGS5/LGN in cystic kidney disease has yet to be
studied using animal models.
Activator of G-protein Signaling 11 (AGS11)
In Birt-Hogg-Dubé (BHD) syndrome, which is a rare genetic
disease caused by mutations in the folliculin (FLCN) gene, renal
cystic epithelial cells exhibit increased nuclear localization of
AGS11/TFE3 (Chen et al., 2008). Further studies are needed
to confirm whether Gα16 plays a role, if any, in the nuclear
localization through a dimeric interaction with AGS11/TFE3 in
this genetic disease.
Heat Shock Protein 90 (HSP90)
In mouse Pkd1−/− and human ADPKD kidneys, the expression
of HSP90 was markedly elevated in the cystic tubular epithelial
cells compared to wild-type control kidneys (Seeger-Nukpezah
et al., 2013). Blockade of HSP90 using a pharmacological
inhibitor reduced cystic disease progression in the kidney
(Seeger-Nukpezah et al., 2013) and liver (Smithline et al., 2014).
At present, however, the role of the HSP90-Gα12 in animal
models of ADPKD remains to be determined, but there is
evidence that Gα12 can directly interact with PC-1 (Yu et al.,
2011) and HSP90 can be associated with the cilia (Prodromou
et al., 2012). Activity of Gα12-dependent apoptosis was associated
with the level of PC-1 expression i.e., over-expression of PC-
1 promotes Gα12 activity whereas knockdown of PC-1 leads to
reduced Gα12 activity (Vaiskunaite et al., 2001). The regulation of
Gα12 activation by PC-1 may in part include HSP90 at the level
of the cilia, so further studies would be necessary to confirm the
relationship between PC-1/ Gα12/HSP90 in the context of cystic
disease progression.
Tubulin
Microtubules are considered to be a major constituent of the
cell, particularly in the cilia and centrosomes, and these cellular
features that have been implicated in the pathogenesis of cystic
disease (Woo et al., 1997). In animal models of polycystic kidney
disease, drugs that promoted microtubule assembly were capable
of reducing the cystic disease progression and significantly
extended the survivability of the cystic mice (Woo et al., 1997).
The mechanism by which G-protein subunits interact with
tubulin to control the dynamics of microtubule assembly during
cystic disease remains to be fully characterized. Loss of cilia
increases the acetylation of α-tubulin, but the total pool of β-
tubulin remains unchanged (Berbari et al., 2013). Alternatively,
abnormalities in the mitotic spindle orientation may be involved
in the pathogenesis of cystic kidney, but not in all genetic forms
of PKD (Fischer et al., 2006; Saburi et al., 2008; Luyten et al.,
2010; Nishio et al., 2010). As a potential mechanism of action,
accessory proteins acting as GDI, such as AGS3 or AGS5/LGN,
which are known to control mitotic spindle orientation may be
perturbed in cystic epithelial cells leading to their misalignment
from the normal axis. Further studies focusing on the importance
of tubulin interaction with G-protein subunits are crucial in
elucidating the etiology of cystogenesis using orthologousmodels
of PKD in the absence or over-expression of specific accessory
proteins.
Ischemia-reperfusion Injury
Acute kidney injury (AKI) is a major clinical problem observed
in hospitalized children and adults, and is commonly associated
with hypoperfusion of the kidney and sepsis (Basile et al., 2012;
Ferenbach and Bonventre, 2015). Imbalances in the regulation of
G-protein signaling is known to partially impact the full recovery
of the damaged tubular epithelia, and this incomplete repair of
the kidney can lead to chronic kidney abnormalities and loss
of renal function. The following accessory proteins have been
described to interact with G-protein subunits and regulate renal
function:
Regulator of G-protein Signaling 4 (RGS4)
In RGS4-deficient mice, renal tubular epithelial cells were highly
susceptible to ischemia-reperfusion injury (IRI). Smooth muscle
cell (SMMC)-specific knockout of RGS4 in mice exhibited
increased mortality following bilateral IRI compared to the
control SMMC-Cre mice. Conversely, transgenic mice over-
expressing RGS4 were protected from IRI (Pang et al., 2015). The
loss of RGS4 following ischemia was associated with a marked
reduction in total renal blood flow (Siedlecki et al., 2011), and
reduced inflammatory cytokine production from macrophages
(Pang et al., 2015). Early after reperfusion following ischemia,
RGS4 competed with downstream effectors for Gαq subunits
activated by ANGII to prevent the normal induction of Regulated
on Activation, Normal T cell Expressed and Secreted (RANTES)
following angiotensin II-stimulated in isolated vascular smooth
muscle cells (Pang et al., 2015).
Activator of G-protein Signaling 1 (AGS1)
Following bilateral renal IRI, AGS1 mRNA levels were markedly
induced by five-fold after 24 h compared to time-control
sham rats (Lenarczyk et al., 2015). There is recent studies
demonstrating that dexamethasone administration has a
protective effect on the kidney following renal IRI in part
by inducing the expression of anti-apoptotic protein, serum
and glucocorticoid regulated kinase-1 (SGK-1) (Rusai et al.,
2013), or preventing the activation of PI3K/Akt signaling on
the inflammatory response system (Zhang et al., 2013). It is
intriguing to consider that dexamethasone may also promote
AGS1 induction as an alternate mode of action to provide
protection to the kidney following renal IRI. Further studies in
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genetically modified mice will be necessary to confirm the role of
AGS1 in the kidney.
Activator of G-protein Signaling 3 (AGS3)
Following ischemia-reperfusion injury, AGS3/GPSM1 protein
expression was selectively induced in the recovering outer
medullary proximal tubular epithelial cells (Regner et al., 2011;
Lenarczyk et al., 2015). A genetic deletion in exon 2 of the
Gpsm1 gene resulted in an absence of full-length AGS3/GPSM1
protein expression, which caused tubular epithelial cell damage
to persist following IRI compared to the wild-type mice (Regner
et al., 2011). The inability of the renal proximal tubular epithelial
cells to recover in the Gpsm1−/− mice following IRI was
partially associated with a decreased number of Ki67-positive
cells. Endogenous knockdown of AGS3/GPSM1 in normal rat
kidney (NRK-52E) epithelial cells reduced cell number, but
the signaling mechanisms regulated by AGS3/GPSM1 during
conditions that simulate acute renal cell injury is largely
undescribed. As described earlier, AGS3/GPSM1 is capable of
sequestering Gαi subunits to prevent the inactivation of Gβγ
signaling (Nadella et al., 2010; Regner et al., 2011; Kwon et al.,
2012). However, there is evidence to suggest that AGS3/GPSM1
regulates macroautophagy, an emerging mode of action that
promotes tubular epithelial cell recovery following AKI, by
direct interaction with Gαi3 subunits (Pattingre et al., 2003,
2004; Ghosh et al., 2010; Groves et al., 2010). Alternatively, we
could speculate that AGS3/GPSM1 influences signal transduction
pathways through other protein-protein interactions, such as
liver kinase B1 (LKB1) (Blumer et al., 2003), which is a
serine/threonine kinase known to regulate AMPK signaling
during states of energetic stress (Alexander and Walker, 2011).
Further studies are needed to define the signaling pathways
modulated by AGS3/GPSM1 to control cell survival during states
of energy depletion and recovery in renal tubular epithelial
cells.
Receptor for Activated C Kinase (RACK1)
A marked temporal induction of RACK1 exclusively in the
damaged and recovering proximal tubular epithelial cells was
observed during the initial 7 day period after renal ischemia-
reperfusion injury (Padanilam and Hammerman, 1997). The
functional consequences for RACK1 during tubular epithelial cell
recovery remain unknown, since mice with a global deficiency
in RACK1 expression exhibit premature lethality (Volta et al.,
2013). Selective deletion of RACK1 in the kidneys, and possibly
to the renal tubular system, will be necessary to eventually define
the importance of RACK1 in the kidney during acute kidney
injury.
Heat Shock Protein 90 (HSP90)
HSP90 expression was induced in the S3 segment of the proximal
tubules following IRI (Morita et al., 1995). Pharmacological
inhibition of HSP90 reduced the tubular epithelial cell damage
following ischemia-reperfusion injury, and was associated with
an induction of other heat shock protein 70 and 27, which
can activate cytoprotective pathways (Harrison et al., 2008).
Conversely, over-expression of HSP90α/β in the kidney was
partially effective in reducing tubular epithelial cell injury
following ischemia-reperfusion injury, which was associated
with the re-establishment in the coupling of endothelial nitric
oxide synthase (eNOS) (Barrera-Chimal et al., 2014). To date,
the role by which G-protein signaling through the dimeric
interaction between HSP90 and Gα12 or Gβγ subunits to control
epithelial cell damage and recovery following AKI needs further
investigation.
Renal Vascular Effects and Blood Pressure
Regulation
The kidney is considered as a major controller of long-
term blood pressure regulation due to its infinite ability to
excrete fluid and electrolytes (Cowley, 1992). Changes in either
tubular or blood flow distribution are involved in the ability
of the kidneys to control blood pressure in mammals. To
date, there is a paucity of data regarding the role of accessory
proteins regulating renal function to control long-term blood
pressure.
Regulator of G-protein Signaling 2 (RGS2)
In Rgs2-deficient mice (Hercule et al., 2007; Gurley et al., 2010),
elevated mean arterial blood pressures have been measured
compared to wild-type RGS2 littermates, and that the differences
in the magnitude in blood pressures were further exaggerated
during the night (Hercule et al., 2007). To assess the importance
of the kidney to mediate the increased blood pressure, an
elegant cross-transplantation study was performed in which
Rgs2−/− kidneys were transplanted into normal C57Bl/6 mice
(Gurley et al., 2010). An increase in mean arterial pressure
of 7–10mmHg was measured in the renal Rgs2−/− mice
compared to the wild-type C57Bl/6 mice or the systemic Rgs2−/−
mice transplanted with normal Rgs2+/+ kidneys. Following
stimulation with various vasoconstrictors, including angiotensin
II (ANGII), phenylephrine, and endothelin-1, the sensitivity
of renal interlobar arteries from Rgs2−/− mouse kidneys were
significantly higher compared to the same vessels from wild-
type mouse kidneys (Hercule et al., 2007). These data would
suggest that RGS2 could control blood pressure levels through
a renal-dependent mechanism that was associated with either
changes in vascular tone and/or tubular reabsorption of fluid and
electrolytes.
RACK1
Expression and localization of RACK1 was differentially
regulated in spontaneously hypertensive rat (SHR) pre-
glomerular vascular smooth muscle cells compared to their
wild-type Wistar Kyoto (WKY) rat counterparts (Cheng et al.,
2013). RACK1 interaction with Gβγ was proposed to redistribute
the complex to the membrane and function as a scaffold to
bridge other signaling molecules (i.e., protein kinase C and
phospholipase C) for downstream activation of diacylglycerol
and calcium (Cheng et al., 2013). This effect was dependent
upon activation of neuropeptide receptors to liberate Gβγ
from its Gαi subunit, and was substantially more active in
the SHR vs. WKY vascular cells to promote proliferation
(Cheng et al., 2013). The physiological impact on renal vascular
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resistance and overall blood pressure regulation remains to be
determined.
Renal Fibrosis
Renal fibrosis is a classic phenotype in the progression of
many types of renal disease, and occurs when the deposition
of extracellular matrix components begin to replace the normal
tubular epithelial cells (Chevalier et al., 2009; Meng et al.,
2014).
RGS2
Using a rodent model of unilateral ureteral obstruction (UUO),
which can simulate progressive renal fibrosis, RGS2 was shown
to beneficially slow the progression of kidney fibrosis (Jang
et al., 2014). In this study, the authors demonstrated that RGS2
protein levels were markedly increased after 5 days following
the UUO procedure with no difference in Gαq levels. Moreover,
there was increased production of both fibrotic markers, α-
smooth muscle action and collagen, and inflammatory markers,
F4/80, Ly6G, myeloperoxidase, and CXCR4, in the UUO-treated
kidneys from the Rgs2-deficient mice. Further in vitro studies
showed that over-expression of RGS2 could block the ANGII-
mediated activation of ERK1/2 signaling and prevent the increase
in CXCR4 expression. This study provides evidence that RGS2
attenuated the onset of renal fibrosis in part by accelerating the
deactivation of the angiotensin type 1 receptor (AT1R)-mediated
signaling of the pro-fibrogenic and inflammatory systems (Jang
et al., 2014).
Glomerular Injury
The glomerulus is an important anatomic structure in the
kidney that consists of a tuft of capillaries that is encapsulated
by Bowman’s capsule, and other important distinct cell
types, including the podocytes, mesangial cells, and basement
membrane, that are involved in controlling the permeability
and selectivity parameters for filtration of the blood into the
tubular lumen (Alpern et al., 2013). Injury to the glomerulus
by genetic or environmental factors can lead to pathologies that
promote abnormal protein excretion and possibly, chronic renal
failure. Emerging new studies have been described regarding
the potential role of accessory proteins following injury to the
glomerulus.
Gα Interacting, Vesicle-associated Protein
(GIV)/Girdin
GIV/Girdin was initially identified to interact with G-protein
αi3/s subunit, and subsequently characterized as a GEF (Garcia-
Marcos et al., 2015) exhibiting diverse biological effects, including
cell migration, autophagy, survival and intracellular protein
trafficking (Garcia-Marcos et al., 2015). In the kidney, however,
the gene expression of GIV/Girdin under normal homeostasis
is relatively sparse. During glomerular damage, the production
of a copious amount of GIV/Girdin can be induced selectively
within the podocytes (Wang et al., 2015), and this regulates the
activation of the PI3K/Akt survival pathway. Ultimately, this
provides enhanced protection from the injury stimuli mediated
by the chemical administration of puromycin aminonucleoside
(PAN) (Wang et al., 2015).
Rap1 GTPase-activating Protein (Rap1GAP)
In transgenic mice expressing human immunodeficiency virus
type 1 (HIV-1), the expression of Rap1GAP was induced
selectively in renal glomerular podocytes (Potla et al., 2014).
Increased expression of Rap1GAP was also detected in kidney
samples obtained from patients with focal and segmental
glomerulosclerosis (FSGS) (Potla et al., 2014). The induction
of Rap1GAP was associated with the podocyte dysfunction
after injury by impairing the mechanisms involved in the
activation of β1-integrin adhesive function. This ultimately
promoted podocyte detachment and exacerbated cellular
death.
Regulator of G-protein Signaling 2 (RGS2)
In children with glomerulonephritis, urotensin II (UII) was
detected in distinct compartments of the glomerulus (Balat
et al., 2007), but its role is not well defined. Recent evidence
in glomerular mesangial cells suggests that RGS2 can reduce
the ability of urotensin II (UII) to increase intracellular calcium
and contraction (Adebiyi, 2014), and demonstrates RGS2 as a
negative regulator of G-protein activity following activation of
the UII/UII receptor axis in the glomerulus.
Renal Cancer
Of the known forms of kidney cancer, the most prevalent is
renal cell carcinoma (RCC), which accounts for more than 80%
of the diagnosed cases and is recognized as the ninth most
common form of cancer in the world (Walker, 1998; Koul
et al., 2011; Jonasch et al., 2014). RCC is generally refractory
to conventional therapies involving drugs and radiation, and so
tumor management is largely treated by partial nephrectomy
of the affected area. G-protein dependent signaling has been
implicated as a contributing factor in the pathogenesis of renal
cancer (Knieke et al., 2009; Jonasch et al., 2014; Ma et al., 2015).
Recent studies have shown that accessory proteins, TFE3/AGS11,
Rap1GAP, and RGS5, were associated with differential expression
patterns and localization within the oncogenic cells compared to
the normal renal parenchyma.
AGS11/TFE3
Xp11 translocation RCC is a group of neoplasms characterized
by translocations involving a genomic breakpoint at Xp11.2.
In these subtypes of renal cancer, genomic DNA containing
either AGS11/TFE3 (Meloni et al., 1993; Weterman et al.,
1996a,b) or AGS12/TFEB (Kuiper et al., 2003) are abnormally
translocated or inverted into other genes (Weterman et al.,
2000, 2001; Mathur and Samuels, 2007), and this is associated
with nuclear localization of AGS11/TFE3 and to a lesser extent,
AGS12/TFEB. Under normal conditions, the protein localization
of AGS11/TFE3 is either observed in predominantly in the
cytoplasm or weakly in the nucleus (Hong et al., 2010). Because
of this shift in subcellular location to the nucleus, AGS11/TFE3
is considered to be one of the diagnostic biomarkers for
specific subtypes of renal cell carcinoma. The mechanism by
which G-protein signaling and nuclear translocation is regulated
during translocation RCC remains to be determined, but there
was some evidence that AGS11-Gα16 accumulation in the
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nucleus promoted robust cardiomyocyte expression of claudin
14, a cell junction protein (Sato et al., 2011). There are an
increasing number of studies investigating the expression of
specific claudin isoforms as pathogenic biomarkers of various
renal cancers (Virman et al., 2014; Men et al., 2015). The
role of AGS11/TFE3 in this transcriptional activation process
may warrant further evaluation in this specific type of renal
cancer.
Rap1GAP
In renal carcinoma, the Rap1GAP protein levels were reduced
leading to increased cellular invasion (Kim et al., 2012). This
is consistent with findings in human thyroid tumors where
downregulation of Rap1GAP expression promoted aberrant
cell migration and invasion, which could be restored back to
normal upon re-expression of RAP1GAP (Tsygankova et al.,
2007). Further studies are needed to confirm the signaling
pathways perturbed by the changes in Rap1GAP function in
the renal oncogenic cells to fully appreciate the impact of these
observational findings.
RGS5
In human RCC, RGS5 was detected specifically in the tumor
vessels, but not in the tumor cells or in the normal capillaries
within the renal parenchyma (Furuya et al., 2004). These
observational studies provide evidence that selective RGS5 signal
modulation in tumor vasculature may play a role in exacerbating
not only human RCC progression, but other types of cancers
(Silini et al., 2012).
Conclusions and Future Perspectives
Although the kidney has a well-documented history of canonical
GPCR-dependent signaling in the renal vascular, glomerular
and tubular system, the role of accessory proteins on G-protein
function has only begun to emerge within the last few years.
As described in this review, the mechanisms associated with the
regulation of heterotrimeric G-protein signaling have continued
to expand far beyond the control by cell surface receptors
activation by their ligands. G-protein signaling through the
actions of accessory proteins can modulate canonical GPCR
signaling, but also enable additional levels of regulation in which
the G-protein signaling can be controlled for its magnitude,
duration, and possibly the site of action. Because of the
unique cellular composition within not only each region of
the kidney (i.e., cortex, outer medulla, and inner medulla), but
also within each segment of the nephron, the expression and
localization patterns of GPCRs, G-protein subunits, and other
accessory proteins demonstrate the enormous task that remains
to completely elucidate the mechanisms involved in the control
of G-protein signaling within each distinct cell type and segment
in the kidney. Further description of these accessory proteins
will enable us to fully appreciate the biological significance of
heterotrimeric G-protein regulation during normal and diseased
states of the kidney.
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